Hackensack Meridian Health

This completed phase 3 trial tested a two-step treatment for multiple myeloma. Patients received high-dose melphalan chemotherapy followed by a stem cell transplant, then a second round with melphalan plus bortezomib (Velcade) and another transplant. The goal was to see if this t…

This study tested whether adding a drug called vorinostat to the standard combination of lenalidomide and dexamethasone could help patients whose multiple myeloma had stopped responding to lenalidomide. The trial enrolled 25 adults with relapsed or refractory multiple myeloma. Th…

This study tested whether adding the drug bortezomib to the standard chemotherapy before a donor stem cell transplant could help people with multiple myeloma live longer without their cancer getting worse. Fifty-four adults received the new drug combo. The main goal was to see if…

This early study tested a new treatment called Stem Cell Educator therapy in 13 adults with type 1 diabetes. The goal was to see if the treatment is safe and possible to do. Researchers used a device to 'educate' the patient's own immune cells outside the body and then return the…

This study tested the drug carfilzomib in 7 people with Waldenström's macroglobulinemia, a rare blood cancer, that had returned after previous treatment. The goal was to see if the drug could shrink tumors and control the cancer. Carfilzomib works by blocking a protein that helps…

This study tested adding thalidomide to two other chemotherapy drugs (bortezomib and melphalan) before a stem cell transplant in 29 people with advanced multiple myeloma who had already tried a similar transplant. The goal was to find the safest dose of thalidomide and see if the…

This study tested adding lenalidomide to a standard chemotherapy regimen (RICE) for people with diffuse large B-cell lymphoma that had come back after initial treatment. The goal was to see if the combination could shrink tumors more effectively, allowing more patients to proceed…

This study tested a treatment for people with previously untreated chronic lymphocytic leukemia (CLL). Participants received a combination of chemotherapy drugs (fludarabine, cyclophosphamide, rituximab) plus lenalidomide, followed by lenalidomide alone to keep the disease under …

This study tested a special pad worn for 4-6 hours to collect cells shed from the uterus. Researchers wanted to see if the pad could gather enough cells to tell the difference between normal tissue, precancerous changes, and cancer. 80 women scheduled for surgery wore the pad, an…

This study tested a smartphone app that analyzes voice recordings to see if it can accurately diagnose mild cognitive impairment (MCI) and Alzheimer's disease. Researchers compared the app's diagnosis to a doctor's diagnosis in 150 adults aged 50 and older. The goal was to see if…

This study tested whether helping people with social needs like housing, food, or transportation could increase lung cancer screening rates. 101 adults aged 50-80 who smoked heavily were split into two groups: one got standard education about lung screening, and the other also go…

This study looked at whether the types of bacteria in the gut and inside tumors affect how well chemotherapy works in triple negative breast cancer. Researchers followed 49 patients receiving standard chemotherapy before surgery. They collected samples to see if certain bacteria …

This study tested whether Facebook ads and a tailored online tool called LungTalk could help people at high risk for lung cancer learn more about screening. Over 500 current or former heavy smokers participated. The goal was to see if social media can effectively reach and educat…